VIDO Saskatoon

• VIDO receives $1M funding boost from Saskatoon couple

  Malcolm and Marilyn Leggett made a $1 million donation to the VIDO on Friday to support ongoing research into infectious diseases.

  Canada

  Aug 27, 2021
  
• VIDO, Global Nexus teaming up to fight COVID-19, future pandemics

  USask and McMaster are partnering to accelerate vaccine and drug development, human and animal clinical trials and create new diagnostic tools.

  Science

  Feb 25, 2021
  
• Advertisement
• Saskatchewan government commits $15M to pandemic research at VIDO

  Premier Scott Moe said $15 million in funding from the province to VIDO is contingent on the federal government committing funds to the project.

  Canada

  Feb 23, 2021
• Advertisement
• Clinical trials start for VIDO’s COVID-19 vaccine candidate

  VIDO hopes its promising tests of the COVID-19 vaccine on ferrets and hamsters will translate into safe and effective results in the human testing phase.

  Canada

  Feb 10, 2021
• VIDO COVID-19 vaccine moves to Phase 1 clinical testing

  Saskatoon-based VIDO says 108 volunteers have been selected to take part in Phase 1 of its COVAC-2 COVID-19 vaccine trial.

  Canada

  Feb 3, 2021
• Saskatoon researcher Dr. Andrew Potter honoured with lifetime achievement award

  Dr. Andrew Potter, the director and CEO of VIDO, has been recognized for years of work in health research.

  Canada

  Jan 19, 2018